The Wilms' tumor gene product (WT1) modulates the response to 1,25-dihydroxyvitamin D3 by induction of the vitamin D receptor

被引:34
|
作者
Maurer, U
Jehan, F
Englert, C
Hübinger, G
Weidmann, E
DeLuca, HF
Bergmann, L
机构
[1] Univ Ulm, Dept Internal Med 3, D-89081 Ulm, Germany
[2] Univ Wisconsin, Coll Agr & Life Sci, Dept Biochem, Madison, WI 53706 USA
[3] Forschungszentrum Karlsruhe, Inst Genet, D-76021 Karlsruhe, Germany
[4] Univ Frankfurt, Dept Internal Med 3, D-60590 Frankfurt, Germany
关键词
D O I
10.1074/jbc.M005292200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Wilms' tumor gene (wt1) encodes a transcription factor involved in urogenital development, in particular in renal differentiation, and in hematopoietic differentiation. Differentiation of a number of solid tumor and leukemic cells lines can be mediated by 1,25-dihydroxyvitamin D-3. This is predominantly mediated by the nuclear receptor for 1,25-dihydroxyvitamin D-3, the vitamin D receptor (VDR). In initial experiments addressing a possible link between WT1 and VDR, we observed a correlated expression of WT1 and VDR mRNA in samples from renal tissues. HT29 colon carcinoma cells, stably transfected to express WT1, exhibited elevated endogenous VDR levels compared with control cells transfected with a control construct. Elevated VDR expression was found in wt1-transfected human embryonic kidney 293 cells, as well. In transient cotransfection experiments, we observed an activation of a vdr promoter reporter by WT1 through a WT1 recognition element, indicating transcriptional regulation of the vdr gene expression by WT1. The responsive sequence element was specifically bound by wild-type, but not by mutated WT1, in electrophoretic mobility shift assays. HT29 colon carcinoma cells, which respond to 1,25-dihydroxyvitamin D, with slow induction of growth arrest, were investigated for the influence of WT1 on 1,25-dihydroxyvitamin D-3-mediated growth suppression. Although HT29 cells transfected with a control construct responded moderately to 1,25-dihydroxyvitamin Dar the response of HT29 cells expressing WT1 was strikingly enhanced, Stimulation with dihydroxyvitamin D, caused an up to 3-fold reduction in the growth rate of different HT29 clones expressing WT1 as compared with control cells lacking WT1 expression. Thus, induction of VDR by WT1 leads to an enhanced response to 1,25-dihydroxyvitamin D-3. We conclude that the vitamin D receptor gene is a target for transcriptional activation by WT1, suggesting a possible physiological role of this regulatory pathway.
引用
收藏
页码:3727 / 3732
页数:6
相关论文
共 50 条
  • [1] Serum Concentrations of 1,25-Dihydroxyvitamin D2 and 1,25-Dihydroxyvitamin D3 in Response to Vitamin D2 and Vitamin D3 Supplementation
    Biancuzzo, Rachael M.
    Clarke, Nigel
    Reitz, Richard E.
    Travison, Thomas G.
    Holick, Michael F.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (03): : 973 - 979
  • [2] The Vitamin D Receptor: New Paradigms for the Regulation of Gene Expression by 1,25-Dihydroxyvitamin D3
    Pike, J. Wesley
    Meyer, Mark B.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2012, 38 (01) : 13 - +
  • [3] The Vitamin D Receptor: New Paradigms for the Regulation of Gene Expression by 1,25-Dihydroxyvitamin D3
    Pike, J. Wesley
    Meyer, Mark B.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2010, 39 (02) : 255 - +
  • [4] Rat oligodendrocytes express the vitamin D3 receptor and respond to 1,25-dihydroxyvitamin D3
    Baas, D
    Prüfer, K
    Ittel, ME
    Kuchler-Bopp, S
    Labourdette, G
    Sarliève, LL
    Brachet, P
    GLIA, 2000, 31 (01) : 59 - 68
  • [5] Induction of transplantation tolerance by 1,25-dihydroxyvitamin D3
    Adorini, L
    Penna, G
    Casorati, M
    Davalli, AM
    Gregori, S
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 58 - 59
  • [6] Analysis of Binding of the 1,25-Dihydroxyvitamin D3 Receptor to Positive and Negative Vitamin D Response Elements
    Darwish, H. M.
    DeLuca, H. F.
    Archives of Biochemistry and Biophysics, 334 (02):
  • [7] Enhancers located in the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3
    Zella, Lee A.
    Kim, Sungtae
    Shevde, Nirupama K.
    Pike, J. Wesley
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2007, 103 (3-5): : 435 - 439
  • [8] The vitamin D receptor functions as a transcription regulator in the absence of 1,25-dihydroxyvitamin D3
    Lee, Seong Min
    Pike, J. Wesley
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2016, 164 : 265 - 270
  • [9] Anti-tumor effects of 1,25-dihydroxyvitamin D3 and vitamin D analogs
    van den Bemd, GJCM
    Pols, HAP
    van Leeuwen, JPTM
    CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (07) : 717 - 732
  • [10] The vitamin D response element of the involucrin gene mediates its regulation by 1,25-dihydroxyvitamin D3
    Bikle, DD
    Ng, D
    Oda, Y
    Hanley, K
    Feingold, K
    Xie, ZJ
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (05) : 1109 - 1113